Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

News Conference News EuroPCR 2023

Virtual, Dynamic Coronary Map Cuts Contrast During PCI: DCR4Contrast

Shelley Wood

May 16, 2023

News Conference News TCT 2019

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

Michael O'Riordan

October 03, 2019

News Daily News

血流动力学指导的补液可减少肾病和心衰患者的造影剂肾病

Todd Neale

December 09, 2015

News Daily News

El Guiado Hemodinámico de la Hidratación Reduce la Nefropatía por Contraste en Pacientes con Enfermedad Renal, Insuficiencia Cardíaca

Todd Neale

December 09, 2015

Presentation TCT 2015

Contrast Nephropathy Clinical Trial Updates (AVERT, RenalGuard, Preserve, and Others)

Presenter: Somjot S. Brar, Richard Solomon, Roxana Mehran

October 15, 2015

News Daily News

RenalGuard 防止 TAVR 患者发生 AKI 的效果优于生理盐水

September 22, 2015

News Daily News

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

September 22, 2015

News Daily News

RenalGuard Evita la LRA en Pacientes TAVR Mejor que una Solución Salina Estándar

September 22, 2015

Presentation

PROTECT-TAVI: AKI With the RenalGuard System in Patients Undergoing TAVR

Presenter: Marco Barbanti

September 21, 2015

Presentation TCT 2014

Clinical Trial Updates: RenalGuard, AVERT, etc.

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon

September 16, 2014

News Industry News

PLC Receives Approval From Japanese Ministry of Health, Labor and Welfare (MHLW) to Conduct 60-Patient Clinical Trial

October 16, 2013

News Industry News

PLC Systems' RenalGuard® Demonstrated At Major Latin American Cardiology Meeting

August 13, 2012

News Industry News

PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital

July 02, 2012

News Industry News

PLC Announces Agreements To Distribute RenalGuard® In Central And South America, Turkey And The United Kingdom

May 30, 2012

News Daily News

Induced Diuresis with Matched Hydration Reduces Contrast Nephropathy

January 17, 2012

News Industry News

PLC Systems Receives FDA Approval to Commence Pivotal Study of RenalGuard in the U.S.

October 14, 2011

News Industry News

PLC Receives Two Additional U.S. Patents and First Japanese Patent For Its RenalGuard® Technology

September 22, 2011

News Daily News

ACT Published: Definitive Results Nix NAC for Preventing Kidney Damage

Caitlin E. Cox

August 26, 2011

News Daily News

REMEDIAL II Published: New Therapy Prevents Contrast-Induced Kidney Damage

Caitlin E. Cox

August 19, 2011

News Industry News

REMEDIAL II Trial of PLC's RenalGuard® Article Published in Circulation

August 18, 2011

Advertisement

Virtual, Dynamic Coronary Map Cuts Contrast During PCI: DCR4Contrast

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

血流动力学指导的补液可减少肾病和心衰患者的造影剂肾病

El Guiado Hemodinámico de la Hidratación Reduce la Nefropatía por Contraste en Pacientes con Enfermedad Renal, Insuficiencia Cardíaca

Contrast Nephropathy Clinical Trial Updates (AVERT, RenalGuard, Preserve, and Others)

RenalGuard 防止 TAVR 患者发生 AKI 的效果优于生理盐水

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

RenalGuard Evita la LRA en Pacientes TAVR Mejor que una Solución Salina Estándar

PROTECT-TAVI: AKI With the RenalGuard System in Patients Undergoing TAVR

Clinical Trial Updates: RenalGuard, AVERT, etc.

PLC Receives Approval From Japanese Ministry of Health, Labor and Welfare (MHLW) to Conduct 60-Patient Clinical Trial

PLC Systems' RenalGuard® Demonstrated At Major Latin American Cardiology Meeting

PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital

PLC Announces Agreements To Distribute RenalGuard® In Central And South America, Turkey And The United Kingdom

Induced Diuresis with Matched Hydration Reduces Contrast Nephropathy

PLC Systems Receives FDA Approval to Commence Pivotal Study of RenalGuard in the U.S.

PLC Receives Two Additional U.S. Patents and First Japanese Patent For Its RenalGuard® Technology

ACT Published: Definitive Results Nix NAC for Preventing Kidney Damage

REMEDIAL II Published: New Therapy Prevents Contrast-Induced Kidney Damage

REMEDIAL II Trial of PLC's RenalGuard® Article Published in Circulation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content